Novel approaches to ocular drug delivery.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Current opinion in molecular therapeutics (Print)

• Publication date

  2004-04-01

• Fields of study

  Medicine, Materials Science

• Identifiers
  PMID 15195932
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suppression of experimental proliferative vitreoretinopathy by sustained intraocular delivery of 5-FU

  2004cited by this paper
• Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix.

  2004cited by this paper
• Recent developments in ocular gene therapy.

  2003cited by this paper
• Intraocular tissue distribution of betamethasone after intrascleral administration using a non-biodegradable sustained drug delivery device.

  2003cited by this paper
• Immune response following intraocular delivery of recombinant viral vectors

  2003cited by this paper
• Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema

  2003cited by this paper
• Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results.

  2003cited by this paper
• Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization.

  2003cited by this paper
• In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.

  2003cited by this paper
• Intravitreal triamcinolone for refractory pseudophakic macular edema.

  2003cited by this paper
• Intravitreal injection of triamcinolone for diffuse diabetic macular edema.

  2003cited by this paper
• Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate.

  2003cited by this paper
• Mechanism of Corneal Permeation of L-Valyl Ester of Acyclovir: Targeting the Oligopeptide Transporter on the Rabbit Cornea

  2002cited by this paper
• Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration

  2002cited by this paper
• P-glycoprotein expression in human retinal pigment epithelium.

  2002cited by this paper
• Transscleral diffusion of carboplatin: an in vitro and in vivo study.

  2002cited by this paper
• Cyclodextrin complexes of sulfonamide carbonic anhydrase inhibitors as long-lasting topically acting antiglaucoma agents.

  2002cited by this paper
• Corneal Permeation of Ganciclovir: Mechanism of Ganciclovir Permeation Enhancement by Acyl Ester Prodrug Design

  2002cited by this paper
• Gene delivery using temperature-responsive polymeric carriers.

  2002cited by this paper
• A new delivery system for 5-fluorouracil using prodrug and converting enzyme

  2002cited by this paper
• Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye.

  2002cited by this paper
• Treatment or prevention of herpes simplex virus retinitis with intravitreally injectable crystalline 1-O-hexadecylpropanediol-3-phospho-ganciclovir.

  2002cited by this paper
• Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

  2002cited by this paper
• Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa.

  2002cited by this paper
• Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion

  2002cited by this paper
• Transscleral drug delivery for posterior segment disease.

  2001cited by this paper
• Randomized clinical trial of Surodex steroid drug delivery system for cataract surgery: anterior versus posterior placement of two Surodex in the eye.

  2001cited by this paper
• Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study.

  2001cited by this paper
• Use of an intravitreal sustained-release cyclosporine delivery device for treatment of equine recurrent uveitis.

  2001cited by this paper
• Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis

  2001cited by this paper
• Biodegradable scleral implant for intravitreal controlled release of ganciclovir

  2000cited by this paper
• Transscleral delivery of bioactive protein to the choroid and retina.

  2000cited by this paper
• Microchip technology in drug delivery

  2000cited by this paper
• Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device.

  2000cited by this paper
• Fluocinolone acetonide sustained drug delivery device to treat severe uveitis.

  2000cited by this paper
• Long-term sustained release of ganciclovir from biodegradable scleral implant for the treatment of cytomegalovirus retinitis.

  2000cited by this paper
• Effect of an intravitreal cyclosporine implant on experimental uveitis in horses.

  2000cited by this paper
• INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE‐RELATED MACULAR DEGENERATION

  2000cited by this paper
• Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation.

  1999cited by this paper
• Enhancement of ocular drug penetration.

  1999cited by this paper
• Concomitant and controlled release of dexamethasone and 5-fluorouracil from poly(ortho ester).

  1999cited by this paper
• Effects of daunomycin implants on filtering surgery outcomes in rabbits.

  1998cited by this paper
• Evaluation of Soluble Bioadhesive Ophthalmic Drug Inserts (BODI®) for Prolonged Release of Gentamicin: Lachrymal Pharmacokinetics and Ocular Tolerance

  1998cited by this paper
• An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy.

  1998cited by this paper
• Development of a multiple-drug delivery implant for intraocular management of proliferative vitreoretinopathy.

  1998cited by this paper
• Silicone rubber/hydrogel composite ophthalmic inserts: preparation and preliminary in vitro/in vivo evaluation.

  1998cited by this paper
• Polymer blend implant for ocular delivery of fluorometholone.

  1998cited by this paper
• Intravitreous delivery of dexamethasone sodium m-sulfobenzoate from poly(DL-lactic acid) implants.

  1998cited by this paper
• Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group.

  1997cited by this paper
• Biodegradable scleral implant for intravitreal controlled release of fluconazole.

  1997cited by this paper
• Effect of Brij-78 on systemic delivery of insulin from an ocular device.

  1997cited by this paper
• Release behavior of poly(lactic acid-co-glycolic acid) implants containing phosphorothioate oligodeoxynucleotide.

  1997cited by this paper
• Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits.

  1997cited by this paper
• In Vitro and in Vivo Evaluation in Rabbits of a Controlled Release 5-fluorouracil Subconjunctival Implant Based on Poly(D,L-lactide-co-glycolide)

  1996cited by this paper
• Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.

  1996cited by this paper
• Implantable biodegradable polymeric device in the treatment of experimental proliferative vitreoretinopathy.

  1995cited by this paper
• Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.

  1994cited by this paper
• An intravitreal device providing sustained release of cyclosporine and dexamethasone.

  1994cited by this paper
• A new vitreal drug delivery system using an implantable biodegradable polymeric device.

  1994cited by this paper
• Biocompatibility of a new semisolid bioerodible poly(ortho ester) intended for the ocular delivery of 5-fluorouracil.

  1994cited by this paper
• Characterization of a rat retinal endothelial cell culture and the expression of P-glycoprotein in brain and retinal endothelium in vitro.

  1992cited by this paper
• Ocular ketone reductase distribution and its role in the metabolism of ocularly applied levobunolol in the pigmented rabbit.

  1988cited by this paper
• Esterase activities in adult rabbit eyes.

  1983cited by this paper
• Pilocarpine delivery by hydrophilic lens in the management of acute glaucoma.

  1975cited by this paper

• Spatiotemporally engineered bilayer microneedles for biphasic drug delivery in corneal neovascularization therapy

  2025cites this paper
• Advancements in Ocular Therapy: A Review of Emerging Drug Delivery Approaches and Pharmaceutical Technologies

  2024cites this paper
• Mussel-Inspired Microgel Encapsulated NLRP3 Inhibitor as a Synergistic Strategy Against Dry Eye

  2022cites this paper
• Aspects in controlled drug delivery for topical applications in veterinary medicine

  2022cites this paper
• A Needle-Free Jet Injection System for Controlled Release and Repeated Biopharmaceutical Delivery

  2021cites this paper
• Fouling in ocular devices: implications for drug delivery, bioactive surface immobilization, and biomaterial design

  2021cites this paper
• Leki oryginalne i ich odpowiedniki stosowane w terapii okulistycznej Branded and generic drugs in ophthalmic therapy

  2021cites this paper
• Advances and challenges in the nanoparticles-laden contact lenses for ocular drug delivery.

  2021cites this paper
• Ophthalmic delivery of hydrophilic drugs through drug-loaded oleogels.

  2020cites this paper
• Recent Advances in the Design of Topical Ophthalmic Delivery Systems in the Treatment of Ocular Surface Inflammation and Their Biopharmaceutical Evaluation

  2020cites this paper
• Topical Application of Hyaluronic Acid-RGD Peptide-Coated Gelatin/Epigallocatechin-3 Gallate (EGCG) Nanoparticles Inhibits Corneal Neovascularization via Inhibition of VEGF Production

  2020cites this paper
• RETRACTED ARTICLE: Hyaluronic Acid-Pluronic®F127-Laden Soft Contact Lenses for Corneal Epithelial Healing: In Vitro and In Vivo Studies

  2020cites this paper
• Dry Tablet Formulation of PLGA Nanoparticles with a Preocular Applicator for Topical Drug Delivery to the Eye

  2019cites this paper
• Once Daily Pregabalin Eye Drops for Management of Glaucoma.

  2019cites this paper
• Development of Multiple Microemulsion Eye Drops for Sustained Release of New Glaucoma Drug

  2018cites this paper
• Clinical experiences after the insertion of a Cyclosporine-A drug delivery device in horses with Equine Recurrent Uveitis

  2018cites this paper
• Iontophoresis-aided drug delivery into the eyeball via eyelid skin

  2018cites this paper
• Strategies for modifying drug residence time and ocular bioavailability to decrease treatment frequency for back of the eye diseases

  2018cites this paper
• Applications of polymers in intraocular drug delivery systems

  2017cites this paper
• A new method for treatment severe forms of dry keratoconjunctivitis (preliminary results)

  2017cites this paper
• A novel nanoparticles impregnated ocular insert for enhanced bioavailability to posterior segment of eye: In vitro, in vivo and stability studies.

  2017cites this paper
• ON OPHTHALMIC INSERTS

  2017cites this paper
• Intraocular distribution of topically applied hydrophilic and lipophilic substances in rat eyes.

  2016cites this paper
• Intraocular distribution of topically applied hydrophilic and lipophilic substances in rat eyes

  2016cites this paper
• Rapidly dissolving polymeric microneedles for minimally invasive intraocular drug delivery

  2016cites this paper
• Preparation of arginine–glycine–aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization

  2016cites this paper
• Design and Development of Surfactants Based Elastic Vesicular Drug Carrier System containing Antifungal Drug for Ophthalmic Disorder

  2016cites this paper
• Routes for Drug Delivery: Sustained-Release Devices.

  2016cites this paper
• Intraocular Drug Delivery Technologies: Advancing Treatment of Posterior Segment Disorders of the Eye

  2016cites this paper
• Nanomaterials for Treating Ocular Diseases

  2016cites this paper
• Clinical and histopathological characteristics after subconjunctival implantation of cyclosporine-containing poly-lactic acid microfilm in normal dogs

  2016cites this paper
• Diseases of the uvea, uveitis, and recurrent uveitis

  2016cites this paper
• Eye segment anatomy , drug delivery , mini-tablet , rapid dissolving tablet

  2015cites this paper
• Applications of Polymers in Intraocular Drug Delivery Systems

  2015cites this paper
• Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study.

  2015influential citation
• ON OCULAR INSERTS

  2015cites this paper
• Formulation of an instantly dissolvable solid eye drop device for topical ocular delivery

  2014cites this paper
• A review of topically administered mini‐tablets for drug delivery to the anterior segment of the eye

  2014cites this paper
• Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies

  2014cites this paper
• Ocular Delivery of Biopharmaceuticals

  2014cites this paper
• Ultrasound-enhanced delivery of antibiotics and anti-inflammatory drugs into the eye.

  2013cites this paper
• Minipigs: Applications in Toxicology

  2013cites this paper
• Formulation and Evaluation of Betamethasone Sodium Phosphate Loaded Nanoparticles for Ophthalmic Delivery

  2013cites this paper
• Challenges in Ocular Pharmacokinetics, Pharmacodynamics, and Toxicology

  2013cites this paper
• Ocular Inserts: A Novel Controlled Drug Delivery System

  2013cites this paper
• Prospective Corollary of Ophthalmic Nanomedicine: A Concept Shift toward Chitosan-Based Mucoadhesive Nanomedicine

  2013cites this paper
• Self-assembled phenylalanine-α,β-dehydrophenylalanine nanotubes for sustained intravitreal delivery of a multi-targeted tyrosine kinase inhibitor.

  2013cites this paper
• Anterior Eye Segment Drug Delivery Systems: Current Treatments and Future Challenges

  2013cites this paper
• Solid Lipid Microparticles (SLMS): An Effective Lipid Based Technology for Controlled Drug Delivery

  2012cites this paper
• Drug delivery systems with modified release for systemic and biophase bioavailability.

  2012cites this paper
• Advancement and Tribulations in Ocular Drug Delivery

  2012cites this paper
• Microparticles based on natural and synthetic polymers for ophthalmic applications.

  2012cites this paper
• Nanomedicines Impacts in Ocular Delivery and Targeting

  2012cites this paper
• Contact Lenses for Drug Delivery Achieving Sustained Release with Novel Systems

  2012cites this paper
• Advances in Biodegradable Ocular Drug Delivery Systems

  2011cites this paper
• Clinical experience and long-term outcome after subscleral insertion of a cyclosporine A drug delivery device in horses with immune-mediated keratitis

  2011cites this paper
• Extended cyclosporine delivery by silicone-hydrogel contact lenses.

  2011cites this paper
• Development And In Vivo In Vitro Characterizations Of Timolol Maleate In-Situ Gels

  2011cites this paper
• OPHTHALMIC DRUG DELIVERY SYSTEM: AN OVERVIEW

  2011cites this paper
• Equine recurrent uveitis

  2010cites this paper
• Ocular inserts — Advancement in therapy of eye diseases

  2010cites this paper
• Ocular drug delivery from molecularly-imprinted contact lenses

  2010cites this paper
• Advancements in ocular drug delivery.

  2010cites this paper
• Equine recurrent uveitis: the viewpoint from the USA.

  2010cites this paper
• Drug delivery systems in domestic animal species.

  2010cites this paper
• Biodegradable Implants for Sustained Drug Release in the Eye

  2010influential citation
• A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.

  2010cites this paper
• Monitoring of Glucose Diffusion in Epithelial Tissues with Optical Coherence Tomography

  2008cites this paper
• Current and future ophthalmic drug delivery systems. A shift to the posterior segment.

  2008cites this paper
• Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes.

  2008cites this paper
• Drug Delivery Systems in Ophthalmic Applications

  2008cites this paper
• Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations.

  2008cites this paper
• Safety Evaluation of Ocular Drug Delivery Formulations: Techniques and Practical Considerations

  2008influential citation
• Sustained Delivery and Pharmacodynamics of an Integrin Antagonist for Ocular Angiogenesis

  2007cites this paper
• Depth-resolved monitoring of analytes diffusion in ocular tissues

  2007cites this paper
• Ranibizumab, a mAb against VEGF-A for the potential treatment of age-related macular degeneration and other ocular complications.

  2007cites this paper
• Advances in the topical ocular drug delivery

  2007cites this paper
• Nondestructive quantification of analyte diffusion in cornea and sclera using optical coherence tomography.

  2007cites this paper
• Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging.

  2007cites this paper
• Sustained-Release Ophthalmic Drug Delivery Systems for Treatment of Macular Disorders

  2007cites this paper
• Helper‐dependent adenovirus for the gene therapy of proliferative retinopathies: stable gene transfer, regulated gene expression and therapeutic efficacy

  2007cites this paper
• A pharmacokinetic and safety evaluation of an episcleral cyclosporine implant for potential use in high-risk keratoplasty rejection.

  2007cites this paper
• Pharmacodynamics of a Deep Scleral Lamellar CsA Device in Naturally Occurring ERU

  2006cites this paper
• Chapter 62 – Surgical Management of Equine Recurrent Uveitis

  2006cites this paper
• A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis.

  2006cites this paper
• Molecularly imprinted materials as advanced excipients for drug delivery systems.

  2006cites this paper
• Ocular Barriers to Transscleral Drug Delivery and Pharmacokinetics of an Episcleral Implant

  2006cites this paper
• Contact lenses for drug delivery

  2006cites this paper
• Preclinical evaluation of a novel episcleral cyclosporine implant for ocular graft-versus-host disease.

  2005cites this paper
• Ocular parameters related to drug delivery in the canine and equine eye: aqueous and vitreous humor volume and scleral surface area and thickness.

  2005cites this paper
• Immunization without needles

  2005cites this paper
• Immune-mediated keratitis in horses: 19 cases (1998-2004).

  2005cites this paper
• Topical Drug Delivery for Posterior Segment Disease

  year unknowncites this paper